Related Experiment Videos
Consensus best practice pathway of the UK Scleroderma Study Group: digital vasculopathy in systemic sclerosis
Michael Hughes1, Voon H Ong2, Marina E Anderson3
1Centre for Musculoskeletal Research, Salford Royal NHS Foundation Trust, University of Manchester, Manchester Academic Health Science Centre, Manchester, michael.hughes-6@postgrad.manchester.ac.uk.
Objective:
Digital vasculopathy (comprising RP, digital ulceration and critical digital ischaemia) is responsible for much of the pain and disability experienced by patients with SSc. However, there is a limited evidence base to guide clinicians in the management of SSc-related digital vasculopathy. Our aim was to produce recommendations that would be helpful for clinicians, especially for those managing patients outside specialist centres.
Methods:
The UK Scleroderma Study Group set up several working groups to develop a number of consensus best practice pathways for the management of SSc-specific complications, including digital vasculopathy.
Results:
This overview presents the background and best practice consensus pathways for SSc-related RP, digital ulceration and critical ischaemia. Examples of drug therapies, including doses, are suggested in order to inform prescribing practice.
Conclusion:
A number of treatment algorithms are provided that are intended to provide the clinician with accessible reference tools for use in daily management.